<div id="readability-page-1">05:28 PM EST, 02/09/2026 (MT Newswires) -- Agomab Therapeutics ( AGMB ) said late Monday it closed its initial public offering of 12.5 million American depository shares at a public offering price of $16 per ADS, raising about $200 million in gross proceeds before underwriting fees and expenses.The American depository shares started trading on the Nasdaq Global Select Market on Feb. 6. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AGMB

東部時間 2026 年 2 月 9 日下午 5:28（MT Newswires）-- Agomab Therapeutics（AGMB）週一晚間表示，已完成 1250 萬份美國存托股票的首次公開募股，公開發行價格為每份 ADS 16 美元，籌集了約 2 億美元的總收入，未扣除承銷費用和開支。這些美國存托股票於 2 月 6 日在納斯達克全球精選市場開始交易。MT Newswires 不提供投資建議。未經授權的複製是嚴格禁止的

AgomAb Therapeutics 完成 2 億美元首次公開募股